购物车
  • TargetMol
    您的购物车当前为空

DGAT-1 inhibitor 2

一键复制产品信息
Rating icon 很棒

纯度: 98.36%

货号 T11016Cas号 942999-61-3

DGAT-1 inhibitor 2是有效的DGAT-1抑制剂,具有减肥功效。

DGAT-1 inhibitor 2
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

DGAT-1 inhibitor 2

一键复制产品信息
Rating icon 很棒

纯度: 98.36%

货号 T11016Cas号 942999-61-3

DGAT-1 inhibitor 2是有效的DGAT-1抑制剂,具有减肥功效。

规格价格库存数量
1 mg
¥ 477
现货
2 mg
¥ 695
现货
5 mg
¥ 1,160
现货
10 mg
¥ 1,850
现货
25 mg
¥ 3,430
现货
50 mg
¥ 5,180
现货
100 mg
¥ 7,130
现货
1 mL x 10 mM (in DMSO)
¥ 1,270
现货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车
该分子属于定制产品。TargetMol拥有优秀的合成团队,经验和能力,可以为您提供高性价比的产品。 如您有任何问题,欢迎咨询,我们将竭诚为您服务。
实验操作小课堂
常见问题解答
查看更多
选择批次:
纯度: 98.36%
联系我们 获取更多批次信息

产品介绍


DGAT-1 inhibitor 2 AI Summary
DGAT-1 inhibitor 2 exhibits diverse bioactivities relevant to lipid metabolism. It demonstrates species-specific metabolic stability in hepatocytes and alamethicin-activated microsomes, with varying conversion levels to its acyl glucuronide form. At a concentration of 30 µM, it inhibits the cytochrome P450 enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 by less than 25%. It effectively inhibits DGAT1 and triacylglycerol synthesis, as evidenced by its IC50 values across various assays. The compound displays different plasma clearance rates, volumes of distribution, half-lives, and bioavailabilities across species and administration routes. It has moderate lipophilicity, aqueous solubility, and plasma protein binding, along with demonstrated permeability in both directions in MDCK cells. Notably, it reduces plasma triacylglycerol levels and adipose triacylglycerol synthesis in a dose-dependent manner in rat models. Given these properties, DGAT-1 inhibitor 2 holds promise for therapeutic applications targeting fat metabolism and triglyceride synthesis..
Note: Summary generated by AI. Data source: ChEMBL
生物活性
产品描述
DGAT-1 inhibitor 2 is an effective DGAT-1 inhibitor; anti-obesity drug. Objective: DGAT-1 acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) is one of two known DGAT enzymes that catalyze the final step of triglyceride synthesis. The discovery of transgenic mice and pharmacological studies indicate that inhibiting DGAT1 is a promising strategy for treating obesity and type 2 diabetes.
化学信息
分子量420.5
分子式C24H28N4O3
CAS No.942999-61-3
SmilesCC1(C)Oc2ncnc(N)c2N=C1c1ccc(cc1)C12CCC(CC(O)=O)(CC1)CC2
密度1.39 g/cm3 (Predicted)
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度信息
DMSO: 12 mg/mL (28.54 mM), Sonication is recommended.
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.3781 mL11.8906 mL23.7812 mL118.9061 mL
5 mM0.4756 mL2.3781 mL4.7562 mL23.7812 mL
10 mM0.2378 mL1.1891 mL2.3781 mL11.8906 mL
20 mM0.1189 mL0.5945 mL1.1891 mL5.9453 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments 比如您的给药剂量是10 mg/kg,每只动物体重20g,给药体积100 μLTargetMol | Animal experiments 一共给药动物10只,您使用的配方为5%TargetMol | reagent DMSO + 30%PEG300 + 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为2mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween80, 混匀澄清,再加 600μLSaline/PBS/ddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSOPEG300 / PEG400Tween 80SBE-β-CD玉米油 等, 均可在TargetMol网站点击购买。
1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

Related Tags: buy DGAT-1 inhibitor 2 | purchase DGAT-1 inhibitor 2 | DGAT-1 inhibitor 2 cost | order DGAT-1 inhibitor 2 | DGAT-1 inhibitor 2 chemical structure | DGAT-1 inhibitor 2 formula | DGAT-1 inhibitor 2 molecular weight